年別の研究成果
年別の研究成果
フィンガープリント
Yuka Hayashiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
- 1 類似のプロファイル
過去5年の共同研究と上位研究分野
国/地域レベルにおける最近の外部共同研究。点をクリックして詳細を開くか、または
-
Decrease in HBsAg After TAF Switching from Entecavir During Long-Term Treatment of Chronic Hepatitis B Virus Infection
Tajiri, K., Hayashi, Y., Murayama, A., Muraishi, N., Minemura, M. & Yasuda, I., 2025/01, In: Viruses. 17, 1, 44.研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
Open Access -
Wilson’s Disease Suspected to Involve a Novel Genetic Mutation of ATP7B Gene, Requiring a Differential Diagnosis with Non-alcoholic Steatohepatitis
Minemura, M., Fukuda, R., Tajiri, K., Muraishi, N., Murayama, A., Hayashi, Y., Takahara, T., Noguchi, A. & Yasuda, I., 2025, In: Internal Medicine. 64, 3, p. 375-379 5 p.研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
Open Access -
Impact of post-progression survival in second-line treatment with molecular target agents for unresectable hepatocellular carcinoma
Tajiri, K., Muraishi, N., Murayama, A., Hayashi, Y. & Yasuda, I., 2024/04, In: Hepatology Research. 54, 4, p. 403-408 6 p.研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
1 被引用数 (Scopus) -
Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection
Hayashi, Y., Tajiri, K., Ozawa, T., Angata, K., Sato, T., Togayachi, A., Nagashima, I., Shimizu, H., Murayama, A., Muraishi, N., Narimatsu, H. & Yasuda, I., 2024/08, In: Medicina (Lithuania). 60, 8, 1334.研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
Open Access -
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Tajiri, K., Tsukada, K., Tokimitsu, Y., Motofuji, Y., Kawai, K., Muraishi, N., Murayama, A., Hayashi, Y., Shimizu, Y. & Yasuda, I., 2024/02/01, In: Oncology (Switzerland). 102, 2, p. 131-140 10 p.研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
2 被引用数 (Scopus)
データセット
-
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Tajiri, K. (作成者), Okada, K. (作成者), Ito, H. (作成者), Kawai, K. (作成者), Kashii, Y. (作成者), Tokimitsu, Y. (作成者), Muraishi, N. (作成者), Murayama, A. (作成者), Hayashi, Y. (作成者), Minemura, M. (作成者), Takahara, T. (作成者), Shimizu, Y. (作成者) & Yasuda, I. (作成者), figshare, 2023
DOI: 10.6084/m9.figshare.c.6665748, https://springernature.figshare.com/collections/Long_term_changes_in_thrombocytopenia_and_leucopenia_after_HCV_eradication_with_direct-acting_antivirals/6665748
データセット
-
Supplementary Material for: Objective response and progression free survival contribute to prolong overall survival in atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma.
Tajiri, K. (寄稿者), Tsukada, K. (寄稿者), Tokimitsu, Y. (寄稿者), Motofuji, Y. (寄稿者), Kawai, K. (寄稿者), Muraishi, N. (寄稿者), Murayama, A. (寄稿者), Hayashi, Y. (寄稿者), Shimizu, Y. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24080436, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Objective_response_and_progression_free_survival_contribute_to_prolong_overall_survival_in_atezolizumab_plus_bevacizumab_treatment_for_unresectable_hepatocellular_carcinoma_/24080436
データセット
-
Supplementary Material for: An autopsy of ruptured hepatic angiosarcoma treated by transcatheter arterial embolization
Entani, T. (寄稿者), Tajiri, K. (寄稿者), Noguchi, A. (寄稿者), Murayama, A. (寄稿者), Muraishi, N. (寄稿者), Hayashi, Y. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24259993, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_An_autopsy_of_ruptured_hepatic_angiosarcoma_treated_by_transcatheter_arterial_embolization/24259993
データセット
-
Supplementary Material for: Objective response and progression free survival contribute to prolong overall survival in atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma.
Tajiri, K. (寄稿者), Tsukada, K. (寄稿者), Tokimitsu, Y. (寄稿者), Motofuji, Y. (寄稿者), Kawai, K. (寄稿者), Muraishi, N. (寄稿者), Murayama, A. (寄稿者), Hayashi, Y. (寄稿者), Shimizu, Y. (寄稿者) & Yasuda, I. (寄稿者), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.24080436.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Objective_response_and_progression_free_survival_contribute_to_prolong_overall_survival_in_atezolizumab_plus_bevacizumab_treatment_for_unresectable_hepatocellular_carcinoma_/24080436/1
データセット
-
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Tajiri, K. (作成者), Okada, K. (作成者), Ito, H. (作成者), Kawai, K. (作成者), Kashii, Y. (作成者), Tokimitsu, Y. (作成者), Muraishi, N. (作成者), Murayama, A. (作成者), Hayashi, Y. (作成者), Minemura, M. (作成者), Takahara, T. (作成者), Shimizu, Y. (作成者) & Yasuda, I. (作成者), figshare, 2023
DOI: 10.6084/m9.figshare.c.6665748.v1, https://springernature.figshare.com/collections/Long_term_changes_in_thrombocytopenia_and_leucopenia_after_HCV_eradication_with_direct-acting_antivirals/6665748/1
データセット